News

In Tireless Pursuit

Creator and chair of the Hong Kong Hereditary Breast Cancer Family Registry. Women’s Surgical Chapter founder with the College of Surgeons of Hong Kong—and its first chair. First woman to attain a clinical associate professorship in surgery in Hong Kong. Chief of the breast surgery division at the Tung Wah…...

Read more

Making the Right Connections

The Asian Fund for Cancer Research was well-represented at the 24th Chinese Biopharmaceutical Association (CBA) Annual Conference, held 10 and 11 June 2019, in Guangzhou. The event, conducted in conjunction with the 12th China Bioindustry Convention, included some of the most highly respected biotechnology and pharmaceutical industry companies, institutions and…...

Read more

Commemorate Someone You Love

Did you know that you can donate to the Asian Fund for Cancer Research in honor or in memory of someone in your life who has been impacted by cancer? Whether honoring a cancer survivor or memorializing the life of a family member, friend or co-worker lost to the disease,…...

Read more

WPI researchers create cancer-detecting chip

A mechanical engineering professor at Worcester Polytechnic Institute and his research team believe they have discovered a revolutionary new way to detect cancer. Balaji Panchapakesan said their liquid biopsy chip has been 100% effective in finding breast or lung cancer in more than a dozen patients in early tests, and…...

Read more

HPV and cancer: 9 myths busted

Although the human papillomavirus (HPV) is quite common, the facts surrounding it can be confusing. Who can get HPV? How do they get it? Can it be treated? How safe and effective is the HPV vaccine? These and other questions have led to misinformation among men, women and parents trying…...

Read more

AFCR Statement on the Hong Kong Cancer Strategy

The Asian Fund for Cancer Research made this statement following the Friday, 26 July, announcement and dissemination of the Hong Kong Cancer Strategy: The Asian Fund for Cancer Research proudly supports and is committed to helping vigorously pursue the newly unveiled Hong Kong Cancer Strategy. We will fiercely fight to…...

Read more

Sarcoma Origin Identified

Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in the skeleton…...

Read more

Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer

The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is the world’s first global adaptive clinical trial platform…...

Read more

News digest – NHS staff shortages, HPV vaccine in Rwanda, prostate cancer guidelines and sunscreen chemicals

Read about this week News Digest’s cancer research breakthrough headlines including National screening programs, a new drug for aggressive childhood brain cancer, HPV vaccination in Rwanda, and more. Original article at: https://scienceblog.cancerresearchuk.org/2019/05/11/news-digest-nhs-staff-shortages-hpv-vaccine-in-rwanda-prostate-cancer-guidelines-and-sunscreen-chemicals/...

Read more

Skin and breast cancer drugs approved for NHS use in Scotland

Two cancer drugs have been approved for patients on the NHS in Scotland. An immunotherapy for some people with advanced skin cancer and a targeted drug for some patients with breast cancer got the green light this week. Pembrolizumab (Keytruda) will now be an option for patients whose melanoma has spread to the…...

Read more